144 results on '"Atherosclerotic cardiovascular disease"'
Search Results
2. Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review
3. Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry
4. Association between exposure to air pollution and arterial stiffness in participants with and without atherosclerotic cardiovascular disease
5. Atherosclerotic Cardiovascular Disease Primary and Secondary Prevention in Latino Subgroups
6. Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
7. Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes
8. Geniposide for treating atherosclerotic cardiovascular disease: a systematic review on its biological characteristics, pharmacology, pharmacokinetics, and toxicology
9. Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study
10. The association between objectively-measured sedentary behavior patterns and predicted 10-year ASCVD risk
11. The association of cumulative low-density lipoprotein cholesterol exposure and carotid intima-media thickness in a young adulthood population
12. Cardiovascular disease risk and associated physical activity factors in gastrointestinal cancer survivors
13. The regulatory effect of zinc on the association between periodontitis and atherosclerotic cardiovascular disease: a cross-sectional study based on the National Health and Nutrition Examination Survey
14. An inverse association of dietary choline with atherosclerotic cardiovascular disease among US adults: a cross-sectional NHANES analysis
15. Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: “INSIST” study
16. Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration
17. The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study
18. Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease
19. In-hospital and mid-term follow-up of low-density lipoprotein cholesterol and target-goal attainment among patients with acute cerebral infarction: a retrospective study
20. Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999–2018
21. Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
22. Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
23. Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
24. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
25. Association of at-home and out-of-home eating frequency with the estimated 10-year arteriosclerotic cardiovascular disease risk in rural population: the Henan Rural Cohort Study
26. Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden
27. NT-proCNP levels predict higher atherosclerotic cardiovascular risk profile in patients with proliferative diabetic retinopathy
28. A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study
29. Prevalence, patterns and associated risk factors for dyslipidaemia among individuals attending the diabetes clinic at a tertiary hospital in Central Malawi
30. Anti-atherosclerotic effects of naringenin and quercetin from Folium Artemisiae argyi by attenuating Interleukin-1 beta (IL-1β)/ matrix metalloproteinase 9 (MMP9): network pharmacology-based analysis and validation
31. Economic burden of atherosclerotic cardiovascular disease: a matched case–control study in more than 450,000 Swedish individuals
32. Correlation between serum soluble ASGR1 concentration and low-density lipoprotein cholesterol levels: a cross-sectional study
33. Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study
34. Determinants of incident atherosclerotic cardiovascular disease events among individuals with type 2 diabetic microvascular complications in the UK: a prospective cohort study
35. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
36. A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
37. Association of hyperuricemia combined with sarcopenia on ASCVD risk
38. Population health management in Belgium: a call-to-action and case study
39. Different associations of general and abdominal obesity with upper and lower extremity artery disease among a community population in China
40. Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients
41. The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials
42. Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain
43. Machine learning framework for atherosclerotic cardiovascular disease risk assessment
44. Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease
45. Can Surrogate Markers Help Define Cardiovascular Disease in Youth?
46. Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study
47. The association between breast arterial calcification and atherosclerotic cardiovascular disease in an Australian population-based breast cancer case–control study
48. Adipose-Derived Stem Cell Exosomes and Related microRNAs in Atherosclerotic Cardiovascular Disease
49. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence
50. Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.